Idelalisib as a Bridge to Allogeneic Transplantation in Relapsed/Refractory Lymphoma With Renal Cancer: A Case Report
Giulia Gabrielli(Hospital of the University of Pennsylvania), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Lisa Argnani(Istituto di Ematologia di Bologna), Cinzia Pellegrini(University of Bologna), Michèle Cavo(Unknown), Alessandro Broccoli(Istituto di Ematologia di Bologna)
Cited by 4
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k